Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD010288Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 12 December 2012see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Cystic Fibrosis and Genetic Disorders Group

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Kana R Jat

    Correspondence to: Department of Pediatrics, Government Medical College and Hospital, Chandigarh, India

    [email protected]

    [email protected]

  • Dinesh K Walia

    Department of Community Medicine, Govt. Medical College and Hospital (GMCH), Chandigarh, India

  • Anju Khairwa

    Department of Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Contributions of authors

 Roles and responsibilities

TASK

WHO WILL UNDERTAKE THE TASK?

Protocol stage: draft the protocol

All three authors

Review stage: select which trials to include (2 + 1 arbiter)

All three authors

Review stage: extract data from trials (2 people)

KRJ, AK

Review stage: enter data into RevMan

KRJ, AK

Review stage: carry out the analysis

KRJ, DKW

Review stage: interpret the analysis

All three authors

Review stage: draft the final review

All three authors

Update stage: update the review

All three authors

Sources of support

Internal sources

  • Government Medical College Hospital, Chandigarh, India.

    Support from library regarding literature search and getting full text articles.

External sources

  • No sources of support supplied

Declarations of interest

None.

Acknowledgements

We thank Nikki Jahnke for support in drafting the protocol.

Version history

Published

Title

Stage

Authors

Version

2021 Sep 22

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Review

Kana R Jat, Dinesh K Walia, Anju Khairwa

https://doi.org/10.1002/14651858.CD010288.pub5

2018 Mar 18

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Review

Kana R Jat, Dinesh K Walia, Anju Khairwa

https://doi.org/10.1002/14651858.CD010288.pub4

2015 Nov 04

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Review

Kana R Jat, Dinesh K Walia, Anju Khairwa

https://doi.org/10.1002/14651858.CD010288.pub3

2013 Sep 17

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Review

Kana R Jat, Dinesh K Walia, Anju Khairwa

https://doi.org/10.1002/14651858.CD010288.pub2

2012 Dec 12

Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis

Protocol

Kana R Jat, Dinesh K Walia, Anju Khairwa

https://doi.org/10.1002/14651858.CD010288

Notes

None.

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.